These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 8699599
1. Intratympanic gentamicin therapy for Menière's disease: preliminary comparison of two regimens. Toth AA, Parnes LS. J Otolaryngol; 1995 Dec; 24(6):340-4. PubMed ID: 8699599 [Abstract] [Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Wu IC, Minor LB. Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316 [Abstract] [Full Text] [Related]
3. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease. Colletti V, Carner M, Colletti L. Otol Neurotol; 2007 Feb; 28(2):145-51. PubMed ID: 17255880 [Abstract] [Full Text] [Related]
4. Effects of a single intratympanic gentamicin injection on Meniere's disease. Chung WH, Chung KW, Kim JH, Cho YS, Hong SH. Acta Otolaryngol Suppl; 2007 Oct; (558):61-6. PubMed ID: 17882572 [Abstract] [Full Text] [Related]
5. Intratympanic gentamicin therapy for intractable Ménière's disease. De Beer L, Stokroos R, Kingma H. Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229 [Abstract] [Full Text] [Related]
6. Hearing results following intratympanic gentamicin perfusion for Ménière's disease. Kyrodimos E, Aidonis I, Sismanis A. J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493 [Abstract] [Full Text] [Related]
7. Intratympanic gentamicin for intractable Meniere's disease. Perez N, Martín E, García-Tapia R. Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197 [Abstract] [Full Text] [Related]
8. Intratympanic gentamicin for the treatment of unilateral Meniere's disease. Kaplan DM, Nedzelski JM, Chen JM, Shipp DB. Laryngoscope; 2000 Aug; 110(8):1298-305. PubMed ID: 10942130 [Abstract] [Full Text] [Related]
9. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing. Silverstein H, Wazen J, Van Ess MJ, Daugherty J, Alameda YA. Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280 [Abstract] [Full Text] [Related]
10. Intratympanic gentamicin therapy for Ménière's disease. Hirsch BE, Kamerer DB. Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951 [Abstract] [Full Text] [Related]
11. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ, Fisher LM, Berliner K, Chung J, Green K. Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [Abstract] [Full Text] [Related]
12. Reliability of the vestibular evoked myogenic potential test in assessing intratympanic gentamicin therapy in Meniere's disease. Ozluoglu LN, Akkuzu G, Ozgirgin N, Tarhan E. Acta Otolaryngol; 2008 Apr; 128(4):422-6. PubMed ID: 18368577 [Abstract] [Full Text] [Related]
15. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A, Saika T, Uno A, Nishiike S, Mitani K, Nishimura M, Kitahara T, Fukushima M, Nakagawa A, Masumura C, Sasaki T, Kizawa K, Kubo T. Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [Abstract] [Full Text] [Related]
16. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. Minor LB. Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525 [Abstract] [Full Text] [Related]